Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Blinding01:11

Blinding

3.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.5K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

22
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
22
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

37
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Trajectories of Hematologic Inflammatory Markers and Their Prognostic and Mediating Roles in Nasopharyngeal Carcinoma: A Multi-institutional Cohort Study.

Clinical and experimental otorhinolaryngology·2026
Same author

Disulfiram Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis with Reduced Endothelial Pyroptosis and Neutrophil Adhesion.

Journal of inflammation research·2026
Same author

Correction to: Determinants of long‑term quality of life in nasopharyngeal carcinoma survivors: the roles of household income and performance status.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Artificial intelligence-driven drug discovery: a new era in therapeutic innovation.

Bioorganic & medicinal chemistry·2026
Same author

Determinants of long-term quality of life in nasopharyngeal carcinoma survivors: the roles of household income and performance status.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Bronchoscopic Internal Traction for Airway Foreign Body Removal via Tracheotomy Under ECMO.

The Laryngoscope·2026

Related Experiment Video

Updated: Oct 22, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

770

Interpretable Trials: Is Interpretability a Reason Why Clinical Trials Fail?

Yi-Sheng Chao1, Chao-Jung Wu2, Hsing-Chien Wu3

  • 1Independent Researcher, Montreal, QC, Canada.

Frontiers in Medicine
|August 26, 2021
PubMed
Summary
This summary is machine-generated.

Using poorly interpretable indices in clinical trials may increase the risk of trial failure. This study suggests evaluating index interpretability to improve clinical trial design and patient outcomes.

Keywords:
clinical trialsclinicaltrials.govcomposite measureindicesinterpretability

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Oct 22, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

770
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Health Services Research

Background:

  • Clinical trials increasingly use composite measures, indices, or scales as proxies for variables or outcomes.
  • The interpretability of these derived measures can be challenging, potentially impacting trial success.
  • Poorly interpretable indices may contribute to clinical trial failure.

Purpose of the Study:

  • To investigate the impact of using indices with varying interpretability in clinical trials.
  • To assess the association between index interpretability and clinical trial outcomes.

Main Methods:

  • Categorized index interpretability as fair-to-poor (e.g., frailty indices), good (e.g., Body Mass Index [BMI]), and unknown.
  • Searched clinicaltrials.gov for trials using indices as conditions/diseases or other terms.
  • Grouped trials by status (completed, terminated, active) and tabulated index frequencies.

Main Results:

  • Analyzed 2,115 trials using indices; 244 used frailty indices and 487 used BMI.
  • Trials with unknown index interpretability showed higher usage as conditions/diseases compared to completed/terminated trials.
  • Active trials utilized frailty indices more frequently than completed or terminated trials.

Conclusions:

  • Clinical trial databases offer insights into trial failure mechanisms.
  • Poor index interpretability may be linked to clinical trial failure.
  • Interpretability should be a key criterion for selecting outcome and proxy measures in clinical trials.